NET Chi-Med pancreatic neuroendocrine tumours

Chi-Med begins Phase Ib/II trial of sulfatinib in US

Hutchison China MediTech (Chi-Med) has commenced a Phase Ib/II trial to evaluate the efficacy and safety of sulfatinib as a…